VRDN Competitors & Alternatives
Compare Viridian Therapeutics Inc with similar stocks in the same industry
Biotechnology
VRDN
Main Stock$31.25
Tradestie Score
43
Market Cap
$1.74B
Revenue Growth
-0.6%
Analyst Upside
+33.4%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.00
|
$3.68B | - | 43 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$94.61
|
$3.67B | - | 40 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$13.19
|
$3.59B | 16.5 | 25 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$18.37
|
$3.58B | 8.6 | 43 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$316.83
|
$3.49B | 126.2 | 54 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.73
|
$3.40B | 94.5 | 53 | Compare |
|
QURE
uniQure N.V.
|
$24.59
|
$3.39B | - | 43 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$46.60
|
$3.33B | - | 32 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$20.72
|
$3.31B | - | 44 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
More VRDN Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry